Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats

Annals of Medicine

Volumn 41, Issue 4, 2009, Pages 311-320

  Sun, Qin ^a   Li, Ling ^a   Li, Renzhe ^a   Yang, Mengliu ^a   Liu, Hua ^b   Nowicki, Michael J ^b   Zong, Haihong ^c   Xu, Jun ^d   Yang, Gangyi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Insulin sensitivity; Lipid metabolism; PPAR; SREBP 2; Visfatin

Indexed keywords

GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; LIPID; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; CYTOKINE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; INSULIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, RAT; SREBF2 PROTEIN, RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GLUCOSE METABOLISM; HYPOCHOLESTEROLEMIA; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER; METABOLIC PARAMETERS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; MALE; METABOLISM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CYTOKINES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 67649674970     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890902729760     Document Type: Article

References (31)

1. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066-1084
2. Polonsky KS, Sturis J, Bell GI. Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med. 1996;334:777-783
3. Taylor SI. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes. 1994;43:735-740
4. Staiger H, Haring HU. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diab. 2005;113:67-79.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedmen JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432
6. Steppen CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312
7. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med. 2001;7:941-946
8. Hug C, Lodish HF. Visfatin: A new adipokine. Science. 2005;307:366-367
9. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005; 146:1764-1771
10. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307: 426-430 (Pubitemid 40139988)
11. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14:1431-1437
12. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Science. 2007;318:565. Retraction of: Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Science. 2005;307:426-430
13. Beltowski J. Apelin and visfatin: Unique 'beneficial' adipo-kines upregulated in obesity? Med Sci Monit. 2006;12: RA112-9.
14. Berndt J, Kloting N, Kralisch S. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005;54:2911-2916
15. Hammarstedt A, Pihlajamaki J, Sopasakis VR, Gogg S, Jansson PA, Laakso M, et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab. 2006;91:1181.
16. Chen MP, Chung FM, Chang DM, Tsai JR, Huang HF, Shin SJ, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91:295-299
17. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, et al. Reduced plasma visfatin/pre-B cell colony- enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006;91:3165-3170
18. Oki K, Yamane K, Kamei N, Nojima H, Kohno N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf). 2007; 67:796-800.
19. Yang G, Li L, Tang Y, Boden G. Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: Possible role of the resistin and adiponectin. Biochem Biophys Res Commun. 2006;339: 1190-1196
20. Hua Z, Xi Y, Naili W, Yaou Z, Guoping C. Macrostemono-side A promotes visfatin expression in 3T3-L1 cells. Biol Pharm Bull. 2007;30:279-283
21. Scribner KB, McGrane MM. RNA Polymerase II association with the phosphoenolpyruvate carboxykinase (PEPCK) promoter is reduced in vitamin A-deficient mice. J Nutr. 2003; 33:4112-4117
22. Miyazaki M, Kim YC, Ntambi JM. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsatu-rated fatty acids for triglyceride synthesis. J Lipid Res. 2001; 42:1018-1024
23. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Bio Chem. 2006;286:40236-40241
24. Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Bio Chem. 2003;278:34114-34118
25. Zeng L, Liao H, Liu Y, Lee TS, Zhu M, Wang X, et al. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells. J Bio Chem. 2004;279:48801-48807
26. Wahli W, Braissant O, Desvergne B. Peroxisome proliferators activated receptors: transcriptional regulation of adipogen-esis, lipid metabolism and more. Chem Biol. 1995;2:261-266
27. Schoonjans K, Peinado Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 1996;15:5336-5338
28. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor y (PPARy) deficiency and PPARy agonist improve insulin resistance. J Biol Chem. 2001;276:41245-41254
29. Berthiaume M, Sell H, Lalonde J, Gelinas Y, Tchernof A, Richard D, et al. Actions of PPARy agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1116-23.
30. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627-1635
31. Wente W, Efanov AM, Brenner M, Kharitonenkov M, Koster A, Sandusky GE, et al. Fibroblast growth factor-21 improves pancreatic ß-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes. 2006;55:2470-2478